Scai Superspeciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.67 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit -471.80%
(FY 2023)
- Ebitda -900.00%
(FY 2023)
- Net Worth -108.46%
(FY 2023)
- Total Assets 1885.83%
(FY 2023)
About Scai Superspeciality Hospitals
The Corporate was formerly known as Trivious Heart Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹12.67 Cr.
Devi Gajjar and Bonny Gajjar serve as directors at the Company.
- CIN/LLPIN
U85110GJ2021PTC124963
- Company No.
124963
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Scai Superspeciality Hospitals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devi Gajjar  | Director | 18-Aug-2021 | Current |
| Bonny Gajjar | Director | 18-Aug-2021 | Current |
Financial Performance of Scai Superspeciality Hospitals.
Scai Superspeciality Hospitals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 471.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 108.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scai Superspeciality Hospitals?
Unlock access to Scai Superspeciality Hospitals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹126.65 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 12.42 Cr
- Others : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2024 | Others | ₹2.50 M | Open |
| 30 Jun 2022 | Hdfc Bank Limited | ₹12.42 Cr | Open |
How Many Employees Work at Scai Superspeciality Hospitals?
Scai Superspeciality Hospitals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scai Superspeciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scai Superspeciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
